Schrodinger, Inc. ROE 2019-2024 | SDGR
Current and historical return on equity (ROE) values for Schrodinger, Inc. (SDGR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Schrodinger, Inc. ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $-0.18B | $0.45B | -35.85% |
| 2024-06-30 | $-0.20B | $0.47B | -38.46% |
| 2024-03-31 | $-0.14B | $0.51B | -25.74% |
| 2023-12-31 | $0.04B | $0.55B | 6.91% |
| 2023-09-30 | $0.04B | $0.56B | 7.95% |
| 2023-06-30 | $0.07B | $0.61B | 12.50% |
| 2023-03-31 | $0.01B | $0.59B | 2.81% |
| 2022-12-31 | $-0.15B | $0.45B | -30.80% |
| 2022-09-30 | $-0.15B | $0.46B | -29.94% |
| 2022-06-30 | $-0.15B | $0.49B | -27.39% |
| 2022-03-31 | $-0.14B | $0.53B | -23.75% |
| 2021-12-31 | $-0.10B | $0.56B | -17.01% |
| 2021-09-30 | $-0.08B | $0.58B | -13.27% |
| 2021-06-30 | $-0.04B | $0.61B | -6.74% |
| 2021-03-31 | $-0.01B | $0.63B | -1.83% |
| 2020-12-31 | $-0.02B | $0.62B | -5.20% |
| 2020-09-30 | $-0.02B | $0.63B | -6.06% |
| 2020-06-30 | $-0.04B | $0.30B | -20.87% |
| 2020-03-31 | $-0.03B | $0.30B | -34.52% |
| 2019-12-31 | $-0.03B | $0.10B | -106.12% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||